Compagnie Lombard Odier S Cm A Pharvaris N.V. Transaction History

Compagnie Lombard Odier S Cm A

  • $6.12 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$13.28 - $18.0 $221,377 - $300,060
-16,670 Closed
0 $0
Q3 2021

Oct 28, 2021
BUY
$13.14 - $20.97 $21,549 - $34,390
1,640 Added 10.91%
16,670 $287,000
Q1 2021

Apr 23, 2021
BUY
$25.25 - $40.11 $379,507 - $602,853
15,030 New
15,030 $422,000

Others Institutions Holding PHVS

# of Institutions
51
Shares Held
39.6M
Call Options Held
0
Put Options Held
0
View Full List

About Pharvaris N.V.

PHVS Quotes by TradingView
  • Ticker PHVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,766,000
  • Market Cap $625M
  • Description
  • Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...
More about PHVS
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email